Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr Gerhard Mann
Berlin, Germanybausch-lomb.de ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dr Gerhard Mann is a long-established German pharmaceutical company specializing in ophthalmology and eye care products. Its portfolio includes both prescription and over-the-counter drugs for various ocular conditions such as infections, dry eye syndrome, and viral diseases of the eye. The company’s marketed products include ganciclovir for cytomegalovirus retinitis and other anti-infective agents like ofloxacin (Floxal). It also produces medical devices such as intraocular lenses and contact lens care solutions.
- Therapeutic areas
- OphthalmologyInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on Dr Gerhard Mann.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dr Gerhard Mann.